(Q33218447)

24 July 2017

title

Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry (English)

1 reference

24 July 2017

Fisher E

1 reference

24 July 2017

Wittfoht W

series ordinal

1 reference

24 July 2017

Nau H

series ordinal

1 reference

24 July 2017

publication date

1 January 1992

1 reference

Biomedical Chromatography

24 July 2017

published in

1 reference

24 July 2017

1 reference

24 July 2017

1 reference

24 July 2017

page(s)

24-29

1 reference

describes a project that uses

24 July 2017

gas chromatography-mass spectrometry

1 reference

based on heuristic

inferred from title

cites work

Metabolic activation of valproic acid and drug-mediated hepatotoxicity. Role of the terminal olefin, 2-n-propyl-4-pentenoic acid

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1130060108

Mechanism of anticonvulsant action of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1130060108

Valproic acid hepatic fatalities: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1130060108

Valproic acid hepatic fatalities. II. US experience since 1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1130060108

Valproate-associated hepatotoxicity and its biochemical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1130060108

Asymmetric synthesis and enantioselective teratogenicity of 2-n-propyl-4-pentenoic acid (4-en-VPA), an active metabolite of the anticonvulsant drug, valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1130060108

Valproic Acid and Metabolites: Pharmacological and Toxicological Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1130060108

21 January 2018

Identifiers

DOI

10.1002/BMC.1130060108

1 reference

24 July 2017

1 reference